AstraZeneca aims for $80 billion in sales by 2030
AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot seeks to cement his legacy at the British drugmaker that he helped to save through a bet on cancer treatments.The company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end … Read more